Alterations in gene expression profiles correlated with cisplatin cytotoxicity in the glioma U343 cell line
2010

Cisplatin's Effects on Gene Expression in Glioma Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Carminati Patricia Oliveira, Mello Stephano Spano, Fachin Ana Lucia, Junta Cristina Moraes, Sandrin-Garcia Paula, Carlotti Carlos Gilberto, Donadi Eduardo Antonio, Passos Geraldo Aleixo Silva, Sakamoto-Hojo Elza Tiemi

Primary Institution: Universidade de São Paulo

Hypothesis

How do glioma cells respond to cisplatin treatment in terms of gene expression and cell survival?

Conclusion

Cisplatin treatment significantly alters gene expression in glioma cells, leading to reduced cell survival and increased apoptosis.

Supporting Evidence

  • Cisplatin reduced U343 cell survival rates to less than 1% after 5 days.
  • Apoptosis frequency reached 20.4% for 25 μM cisplatin after 72 hours.
  • 67 genes were significantly modulated, with 29 down-regulated and 38 up-regulated.

Takeaway

This study shows that when glioma cells are treated with cisplatin, many genes change their activity, which helps the cells die more easily.

Methodology

Gene expression was analyzed using cDNA microarrays, and cell survival and apoptosis were measured after treating glioma cells with various concentrations of cisplatin.

Limitations

The study primarily focuses on one cell line, which may not represent all glioma types.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/S1415-47572010005000013

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication